advertisement

Topcon

Bailly M 10

Showing records 1 to 10 | Display all abstracts from Bailly M

73441 An Ilomastat-CD Eye Drop Formulation to Treat Ocular Scarring
Mohamed-Ahmed AHA
Investigative Ophthalmology and Visual Science 2017; 58: 3425-3431
72755 Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis
Yu-Wai-Man C; Spencer-Dene B
Scientific reports 2017; 7: 518
73441 An Ilomastat-CD Eye Drop Formulation to Treat Ocular Scarring
Lockwood A
Investigative Ophthalmology and Visual Science 2017; 58: 3425-3431
72755 Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis
Lee RM
Scientific reports 2017; 7: 518
73441 An Ilomastat-CD Eye Drop Formulation to Treat Ocular Scarring
Li H
Investigative Ophthalmology and Visual Science 2017; 58: 3425-3431
72755 Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis
Hutchings K
Scientific reports 2017; 7: 518
73441 An Ilomastat-CD Eye Drop Formulation to Treat Ocular Scarring
Bailly M; Khaw PT
Investigative Ophthalmology and Visual Science 2017; 58: 3425-3431
72755 Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis
Lisabeth EM
Scientific reports 2017; 7: 518
73441 An Ilomastat-CD Eye Drop Formulation to Treat Ocular Scarring
Brocchini S
Investigative Ophthalmology and Visual Science 2017; 58: 3425-3431
72755 Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis
Treisman R; Bailly M; Larsen SD; Neubig RR; Khaw PT
Scientific reports 2017; 7: 518

Issue 18-4

Change Issue


advertisement

WGA Rescources